New York, New York--(Newsfile Corp. - September 12, 2025) - OS Therapies Inc. (OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results